Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06A ANTIDEPRESSANTS
N06AX Other antidepressants
N06AX23 Desvenlafaxine
D02570 Desvenlafaxine succinate (USAN) <US>
USP drug classification [BR:br08302]
Antidepressants
SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/Serotonin and Norepinephrine Reuptake Inhibitors)
Desvenlafaxine
D02570 Desvenlafaxine succinate (USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01658 Serotonin and norepinephrine reuptake inhibitor (SNRI)
DG00963 Desvenlafaxine
D02570 Desvenlafaxine succinate
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00963 Desvenlafaxine
D02570 Desvenlafaxine succinate
DG02924 UGT substrate
DG00963 Desvenlafaxine
D02570 Desvenlafaxine succinate
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (NAT1)
D02570 Desvenlafaxine succinate (USAN) <US>
SLC6A4 (HTT)
D02570 Desvenlafaxine succinate (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02570
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02570
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02570
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01658 Serotonin and norepinephrine reuptake inhibitor (SNRI)
DG00963 Desvenlafaxine
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00963 Desvenlafaxine
DG02924 UGT substrate
DG00963 Desvenlafaxine